Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soren Brunak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JAMA|October 9, 2019
Identifying Sepsis PhenotypesPope L Moseley, Soren Brunak
Current Pharmaceutical Design|September 9, 2016
In Silico Systems Pharmacology to Assess Drug's Therapeutic and Toxic EffectsAlejandro Aguayo-Orozco, Karine Audouze, Soren Brunak, et al.
AJR. American Journal of Roentgenology|March 11, 2026
Opportunistic Imaging: 2026 Status Update and Future OutlookKirti Magudia, Soren Brunak, Ross W Filice, et al.
Science (New York, N.Y.)|November 20, 2002
Nucleotide sequence database policiesSoren Brunak, Antoine Danchin, Masahira Hattori, et al.
Proteomics. Clinical Applications|February 26, 2015
A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell deathDieter Rondas, Valborg Gudmundsdottir, Wannes D'Hertog, et al.
Diabetologia|June 4, 2024
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA studyTommi Vatanen, Carine de Beaufort, M Loredana Marcovecchio, et al.
Life Sciences, Society and Policy|September 6, 2018
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) projectHarriet J A Teare, Federico de Masi, Karina Banasik, et al.
Diabetologia|August 3, 2023
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectoryRobert Moulder, Tommi Välikangas, M Karoliina Hirvonen, et al.
Nucleic Acids Research|December 2, 2016
Pharos: Collating protein information to shed light on the druggable genomeDac-Trung Nguyen, Stephen Mathias, Cristian Bologa, et al.
Diabetologia|September 30, 2024
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT studySapna Sharma, Qiuling Dong, Mark Haid, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JAMA|October 9, 2019
Identifying Sepsis PhenotypesPope L Moseley, Soren Brunak
Current Pharmaceutical Design|September 9, 2016
In Silico Systems Pharmacology to Assess Drug's Therapeutic and Toxic EffectsAlejandro Aguayo-Orozco, Karine Audouze, Soren Brunak, et al.
AJR. American Journal of Roentgenology|March 11, 2026
Opportunistic Imaging: 2026 Status Update and Future OutlookKirti Magudia, Soren Brunak, Ross W Filice, et al.
Science (New York, N.Y.)|November 20, 2002
Nucleotide sequence database policiesSoren Brunak, Antoine Danchin, Masahira Hattori, et al.
Proteomics. Clinical Applications|February 26, 2015
A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell deathDieter Rondas, Valborg Gudmundsdottir, Wannes D'Hertog, et al.
Diabetologia|June 4, 2024
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA studyTommi Vatanen, Carine de Beaufort, M Loredana Marcovecchio, et al.
Life Sciences, Society and Policy|September 6, 2018
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) projectHarriet J A Teare, Federico de Masi, Karina Banasik, et al.
Diabetologia|August 3, 2023
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectoryRobert Moulder, Tommi Välikangas, M Karoliina Hirvonen, et al.
Nucleic Acids Research|December 2, 2016
Pharos: Collating protein information to shed light on the druggable genomeDac-Trung Nguyen, Stephen Mathias, Cristian Bologa, et al.
Diabetologia|September 30, 2024
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT studySapna Sharma, Qiuling Dong, Mark Haid, et al.
Pageof 2